Now on Pharmaceutical Processing
From a vision to a vial in 12 months - Process development and... Comments
California ePedigree Push to 2015 – What does it mean? Comments
Addressing the Challenges Contract Manufacturing Organizations are... Comments

Subscribe to Pharmaceutical Processing
 






























 

Lundbeck Pharmaceuticals Ltd. - P7 Building, Seal Sands, UK

Facility Considerations
Lundbeck's new multi-million dollar Primary Pharmaceutical Facility at Seal Sands represents the largest single investment made by the company to date. The new high-tech plant manufactures Escitalopram, which is the active ingredient for Cipralex&reg/Lexapro&reg, Lundbeck's new antidepressant drug.

The plant features a large-scale Simulated Moving Bed (SMB) unit in addition to conventional chemical production equipment. SMB is the core technology and enables separation of the enantiomers of Citalopram (Cipramil&reg) and therefore makes production of pure Escitalopram possible.

To construct the new P7 plant at Seal Sands, England, Lundbeck appointed Foster Wheeler Energy Ltd as their Engineering, Procurement, Construction and Validation (EPCV) Contractor.

As 'Speed to Market' was the critical feature of this project, Lundbeck set a challenge to the project team to meet a 21 month schedule, from award of contract to mechanical completion. This schedule represents a 10 month saving on normal projects of this size.

To achieve the desired 'Speed to Market' and ultimate launch of the new drug the entire team had to be committed to the schedule.

Key areas were identified to ensure the fast track nature of the project was successful, they included:

• Extensive use of modularization techniques for all levels of design and construction across all disciplines.
• Contract strategy and subcontractor scope for both design and construction.
• SMB unit ordered by Lundbeck prior to apointment of principal contractor to achieve project timescale.
• Nominated civil and building subcontractor apoointed simulataneously with principal contractor.
• Site works commenced 2 months after award.
• Early appointment of all subcontractors.
• Design Strategy - Non-intelligent model adopted as opposed to PDS.
• Commissioning and Validation team – commenced 3 months after award.
• Fully Integrated team approach.

Processes/Manufacturing Equipment Employed
Process

The process was previously developed and implemented in several smaller production facilities in Denmark. The P7 facility provided a world scale, custom-made production solution for the total manufacture of the API.

Technology

At the heart of the process technology is the Simulated Moving Bed (SMB) Chromatogram system. This is a continuous process operation and was by far the largest implementation of this technology available.

The supplier was Groupe Novasep, based in Nancy, France. Novasep had worked closely with Lundbeck for several years to develop a separation technique suitable for industrial scale enatiomeric separation. Chiral Technlogies Ltd. also worked with Novasep and Lundbeck to provide a suitable stationary phase for the system.

Integration

The facility design concept was based on a modular philosophy - the modular approach was applied to the whole facility and a wide range of equipment. From a construction viewpoint, modules were specified to contractors and constructors on a turnkey basis from detailed design to qualification.
Module fabrication was in many instances performed off site. Larger more complex modules were also assembled on site. The pre-constructed modules were easily integrated into the facility specifically designed to accommodate the modular approach.

The following are significant areas of modularization tendered as complete packages:

• Jacket service units – TFS limited
• Pre Assembled Pipe racks – Cordell
• Compressed Air – Woodside Pneumatics
• Nitrogen - Air Products
• Steam generation unit – Cochrans
• Thermal fluid refrigeration plant – Star Refrigeration
• Adsorber – Sutcliffe Croftshaw

Equipment

Equipment suppliers were pre-specified to the module constructors.
The basis of selection centered on existing Lundbeck specifications and standards. These standards provided a basis for commonality on equipment types, which, in turn:

• Reduced training
• Sped up qualification and validation
• Reduced spares inventory
• Reduced documentation
• Established and improveed relationships with suppliers
• Provided greater potential for financial savings

Some of the equipment choices made at Lundbeck:

• Glass lined reactors – Pfaudler Balfour
• Level, and flow instrumentation – Endress & Hauser
• Temperature, pressure and pH instrumentation – Rosemuont
• Variable Speed drive systems – Vacon
• Pumps- HMD and Flowserve
• Valves- Worcester and Atomac


H. Lundbeck A/S
Otilliavej 9
Valby-Copenhagen, DK, 2500




 
Digital Library




























Bioscience Technology Chromatography Techniques Drug Discovery & Development Laboratory Equipment Pharmaceutical Processing R&D Scientific Computing
Advantage Business Media © Copyright 2008 Advantage Business Media
Privacy Policy | Terms & Conditions | Advertise With Us